Neovasc Investor Relations Material
Latest events
Q3 2022
Neovasc
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Neovasc Inc
Access all reports
Neovasc Inc. is a medical device company that focuses on the development of products for the treatment of cardiovascular diseases. The company's primary offerings include devices designed to address refractory angina, a chronic condition characterized by chest pain, and to support heart valve repair procedures. The company is headquartered in Richmond, Canada, and its shares are listed on the NASDAQ.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
NVCN
Country
🇨🇦 Canada